NicolasWShammasMDEJD, MS

Cardiology • Davenport, IA

Adult Congenital Heart Disease, Cardiac Electrophysiology, Interventional Cardiology, Peripheral Endovascular Interventional Cardiology

Cardiovascular Medicine, PC

Join to view full profile

Dr. Shammas is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Shammas' full profile

Already have an account?

Office
1236 E Rusholme St
Ste 300
Davenport, IA 52803
Phone+1 563-324-2992

Fax+1 563-888-0499

Education & Training

University of Iowa Hospitals and ClinicsFellowship, Cardiovascular Disease, 1994 - 1995
University of RochesterFellowship, Cardiovascular Disease, 1991 - 1994
University of Iowa Hospitals and ClinicsResidency, Internal Medicine, 1988 - 1991
American University of Beirut Faculty of MedicineClass of 1987

Certifications & Licensure

IA State Medical License 1988 - 2027
IL State Medical License 1996 - 2026
American Board of Internal Medicine Cardiovascular Disease
American Board of Internal Medicine Interventional Cardiology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2011-2013
Whos Who in Medicine and Healthcare Marquis Whos Who
Fellow (FACC) American College of Cardiology

Clinical Trials

Ranolazine in Ischemic Cardiomyopathy Start of enrollment: 2011 Apr 01
Completed
Phase 4
Multi-Center Registry for Peripheral Arterial Disease Interventions and Outcomes Start of enrollment: 2013 Jan 01
Recruiting
ENDOvascular Interventions With AngioMAX: The ENDOMAX Trial Start of enrollment: 2013 Sep 24
Terminated
Phase 3
Radiographic Imaging Validation and EvALuation for Angio iFR (ReVEAL iFR) Start of enrollment: 2019 Aug 01
Completed
Prospective, Multi-center, Single-arm Study of the Auryon Laser System for Treatment of Below-the-Knee (BTK) Arteries Start of enrollment: 2022 Mar 17
Active, not recruiting
Not Applicable
Roles: Principal Investigator, Contact
Join now to see all

Publications & Presentations

PubMed

Thirty-day outcomes from the Disrupt PAD BTK II study of the Shockwave Intravascular Lithotripsy System for treatment of calcified below-the-knee peripheral arterial d...
Venita Chandra, Alexandra J Lansky, Sameh Sayfo, Nicolas W Shammas, Peter Soukas
Journal of Vascular Surgery. 2024-11-12
The VIVID trial 12-month outcomes of the venous stent for the iliofemoral vein using the Duo venous stent system.
Mahmood Razavi, Michael Lichtenberg, Kush Desai, David Dexter, Peter Soukas
Journal of Vascular Surgery. Venous and Lymphatic Disorders. 2024-10-29
Intravascular Lithotripsy for Peripheral Artery Calcification: 30-Day Outcomes From the Disrupt PAD III Observational Study.
Ehrin J Armstrong, George Adams, Peter A Soukas, Sarang S Mangalmurti, Nicolas W Shammas
Journal of Endovascular Therapy. 2024-10-18

Journal Articles

WIRION Embolic Protection System in Lower Extremity Arterial Interventions
Herbert D Aronow, J Stephen Jenkins, Nicolas W Shammas, Lawrence A Garcia, Ehrin J Armstrong, ScienceDirect

Lectures

In-Stent Restenosis: How Does Atherectomy Figure in These Cases?
CRF Transcatheter Cardiovascular Therapeutics - Annual Symposium 2019 - Miami, FL - 9/25/2019

Press Mentions

AVS Enrolls First Patient in U.S. Pivotal Intravascular Lithotripsy StudyOctober 15th, 2024
AVS’s Pulse IVL POWER PAD II Pivotal Trial Begins EnrollmentOctober 15th, 2024
AngioDynamics’ Auryon Atherectomy System Receives European CE Mark ApprovalSeptember 3rd, 2024
Join now to see all

Professional Memberships

American College of Cardiology - ACC
Member

Other Languages

French, Arabic